Bimeda is pleased to announce the release of our second Annual Sustainability Report. Published in February 2024, this report provides a comprehensive overview of the initiatives undertaken throughout 2023 to uphold our sustainability commitments acr...
Irish-owned global animal health company Bimeda is pleased to today mark the official opening of its state-of-the-art sterile injectable manufacturing facility in Shijiazhuang, China, with a ceremony ...
Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...
Global animal health company, Bimeda, is pleased to announce the establishment of a new business unit in Europe. Bimeda Nordic ApS, is headquartered in Odense, Denmark and will supply Bimeda products ...
Bimeda is pleased to announce the acquisition of AquaTactics Fish Health ("AquaTactics"), based in Seattle, Washington. The company was founded in 2009 by Dr Tom Goodrich and Hugh Mitchell DVM. The co...
Bimeda is pleased to announce that its state-of-the-art manufacturing facility in Hebei, China, has just received its Chinese GMP accreditation. This sterile injectable manufacturing facility is desi...
Bimeda is pleased to announce its acquisition of the Grupo Unipharm veterinary medicine portfolio, consisting of 25 licensed veterinary products and over 150 licenses. The acquisition will further str...